Your browser doesn't support javascript.
loading
Early B cells repopulation in multiple sclerosis patients treated with rituximab is not predictive of a risk of relapse or clinical progression.
Dorcet, Guillaume; Migné, Hugo; Biotti, Damien; Bost, Chloé; Lerebours, Fleur; Ciron, Jonathan; Treiner, Emmanuel.
Afiliação
  • Dorcet G; Department of Neurology, CRC-SEP, University Hospital of Toulouse, Toulouse, France.
  • Migné H; INSERM U1291-CNRS 5051, INFINITy, Toulouse, France.
  • Biotti D; Immunology Laboratory, Biology Department, University Hospital of Toulouse, Toulouse, France.
  • Bost C; Department of Neurology, CRC-SEP, University Hospital of Toulouse, Toulouse, France.
  • Lerebours F; INSERM U1291-CNRS 5051, INFINITy, Toulouse, France.
  • Ciron J; INSERM U1291-CNRS 5051, INFINITy, Toulouse, France.
  • Treiner E; Immunology Laboratory, Biology Department, University Hospital of Toulouse, Toulouse, France.
J Neurol ; 269(10): 5443-5453, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35652942
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Neurol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Neurol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França